Pascoal Lab
  • Home
  • Our Research
    • Studies
    • Publications
  • Lab
    • About Us
    • News
    • Funding
    • Gallery
  • Our Team
    • PI
    • Meet the Team
    • Alumni
  • Contact
Select Page
Genetic risk of ADHD may boost odds of Alzheimer’s in old age

Genetic risk of ADHD may boost odds of Alzheimer’s in old age

by Fernando Rigon | Dec 8, 2022 | News

Having a genetic predisposition to attention-deficit/hyperactivity disorder, or ADHD, is associated with cognitive decline and may predict Alzheimer’s disease in old age, early research released Thursday suggests. Recent large studies have hinted at a link...
Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults

Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults

by Fernando Rigon | Oct 12, 2022 | News

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects 2.5% of adults worldwide. Pharmacotherapy is the recommended initial treatment for most adults, but patient adherence can be low due to adverse effects and other concerns....
Molecular Psychiatry: Astrocyte Biomarker Signatures of Amyloid-β and Tau Pathologies in Alzheimer’s Disease

Molecular Psychiatry: Astrocyte Biomarker Signatures of Amyloid-β and Tau Pathologies in Alzheimer’s Disease

by Fernando Rigon | Sep 29, 2022 | News

In Alzheimer’s disease, reactive astrocytes can play an important role in the pathophysiology of the disease. Amyloid-β and tau tangles—the two main pathological hallmarks of Alzheimer’s disease—are associated with astrocyte reactivity. However, knowledge about...
Pitt Psychiatry Awarded $33.5M NIH Program Project Grant Focused on the Pathological and Clinical Progression of AD

Pitt Psychiatry Awarded $33.5M NIH Program Project Grant Focused on the Pathological and Clinical Progression of AD

by Fernando Rigon | Sep 14, 2022 | News

The National Institute on Aging (NIA) has awarded the University of Pittsburgh Department of Psychiatry a Program Project Grant (PPG) renewal for “The role of astrogliosis in aging and the pathological and clinical progression of Alzheimer’s disease.” The...
Study Challenges Dogma Behind Alzheimer’s Disease Drug Trials

Study Challenges Dogma Behind Alzheimer’s Disease Drug Trials

by Fernando Rigon | Jul 19, 2022 | News

PITTSBURGH – Contrary to early studies, brain levels of enzymes that regulate DNA-folding drop as Alzheimer’s disease progresses, neuroscientists from the University of Pittsburgh, McGill University and Harvard University reported...
Page 1 of 3123»

Recent Posts

  • Genetic risk of ADHD may boost odds of Alzheimer’s in old age
  • Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults
  • Molecular Psychiatry: Astrocyte Biomarker Signatures of Amyloid-β and Tau Pathologies in Alzheimer’s Disease
  • Pitt Psychiatry Awarded $33.5M NIH Program Project Grant Focused on the Pathological and Clinical Progression of AD
  • Study Challenges Dogma Behind Alzheimer’s Disease Drug Trials

3501 Forbes Ave (Oxford Building), 7th floor
Pittsburgh, PA 15213

Email Us

If you are interested in joining our lab, please send an email describing your current position, why you would like to join the lab and for how long.

join us
  • Follow

Website by